Clinical Trial

Molecular Pituitary Imaging Using 18F-FET PET

Study acronym: FET-pit-PET
Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this single centre pilot study is to explore whether 18F-fluoro-ethyl-tyrosine PET (FET-PET) yields comparable findings to 11C-methionine PET (Met-PET) for the localisation of pituitary tumours.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-08-30.
Status change: Not Yet Recruiting → Recruiting 2026-01-05
Trial Details
NCT Number NCT06584123
Lead Sponsor University of Cambridge
Collaborators: Cambridge University Hospitals NHS Foundation Trust
Conditions Pituitary Adenoma
Enrollment 20 participants
Start Date 2024-09-03
Primary Completion 2026-09-02 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-01-06